𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Non-Hodgkin’s Lymphoma among Patients Infected with Human Immunodeficiency Virus: The Experience of a Single Center in Brazil

✍ Scribed by Paula Yurie Tanaka; Luis Fernando Pracchia; Edenilson Eduardo Calore

Publisher
Carden Jennings Publishing
Year
2007
Tongue
English
Weight
29 KB
Volume
86
Category
Article
ISSN
0925-5710

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-Hodgkin's lymphoma in four children
Non-Hodgkin's lymphoma in four children infected with the human immunodeficiency virus. Association with Epstein-Barr virus and treatment
✍ David Nadal; Rosmarie Caduff; Eva Frey; Shabir Hassam; Dieter R. Zimmermann; Jea 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 668 KB

Background. Reports on lymphoid malignancy and its treatment in children infected with human immunodeficiency virus (HIV) are limited. Methods. Antibodies to Epstein-Barr virus (EBV) were detected by indirect immunofluorescence. DNA was extracted from peripheral blood lymphocytes or biopsy specimen

Prognostic factors after non-Hodgkin lym
Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus : Aquitaine cohort, France, 1986–1997
✍ Frantz Thiessard; Philippe Morlat; Catherine Marimoutou; Eric Labouyrie; Jean-Ma 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## BACKGROUND. The prognosis for survival of patients infected with the human immunodeficiency virus (HIV) who develop non-Hodgkin lymphoma (NHL) usually is considered to be poor. To the authors' knowledge the impact of highly active antiretroviral therapy, recently introduced in HIV disease case m

Intensive sequential chemotherapy with h
Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus
✍ Régis T. Costello; Hacène Zerazhi; Aude Charbonnier; Jean-Marc Schiano de Colell 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

## Abstract ## BACKGROUND Optimal treatment of human immunodeficiency virus (HIV)‐associated non‐Hodgkin lymphoma (NHL) has yet to be defined, because chemotherapy could exacerbate immunodeficiency, with subsequent adverse effects for patients. ## METHODS The authors investigated the feasibility